Skip to main content
Premium Trial:

Request an Annual Quote

Hitachi Life Sciences Expects Growth Spurt

Premium

Hitachi, which signed a 10-year instrument development deal with Nanogen last month, is projecting wild growth for its life sciences division. The division combined a corporate infusion with a $9 million grant it received last year from Japan’s Ministry of International Trade and Industry to gear up to tackle the genomics market.

The division has merged with Hitachi’s instruments and information groups in Kawagoe City, and broadened its services to address high-throughput sequencing, SNP scanning and scoring, expression profiling, protein network analysis, and bioinformatics. Jointly with Applied Biosystems, Hitachi recently introduced a 16-capillary small-scale sequencing machine.

Takao Iwayanagi, chief technology officer for the life sciences group says he expects revenues this year of $7.2 million. But by 2002, he expects to multiply that almost 20-fold to reach revenues of $135 million.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.